DAVID L GRANGE
CIK 1264908 · Chief Executive Officer · last filed 2026-05-14
DAVID L GRANGE is a Chief Executive Officer who has filed 23 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for TNXP, was dated May 14, 2026. Across all open-market trades the lifetime net is −$3.0M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
23
-$3.03M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TNXP | Director | — | $11.35 | — | $0 | 10 | 2026-05-14 |
| PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI) Delisted | Chief Executive Officer | 61,045 | — | — | -$3.03M | 13 | 2011-03-01 |
Recent Filings
23 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-14 | TNXP | Grant (A) | — | $0 | EDGAR |
| 2025-05-15 | TNXP | Grant (A) | — | $0 | EDGAR |
| 2024-05-24 | TNXP | Grant (A) | — | $0 | EDGAR |
| 2023-05-10 | TNXP | Grant (A) | — | $0 | EDGAR |
| 2022-05-11 | TNXP | Grant (A) | — | $0 | EDGAR |
| 2021-05-12 | TNXP | Grant (A) | — | $0 | EDGAR |
| 2020-05-06 | TNXP | Grant (A) | — | $0 | EDGAR |
| 2019-05-08 | TNXP | Grant (A) | — | $0 | EDGAR |
| 2018-06-13 | TNXP | Grant (A) | — | $0 | EDGAR |
| 2018-02-15 | TNXP | Grant (A) | — | $0 | EDGAR |